Search

Palma-Álvarez, Raul Felipe, Constanza Daigre, Germán Ortega-Hernández, Elena Ros-Cucurull, Ana Rios-Landeo, Paula Gamboa, Marta Perea-Ortueta, et al. 2025. “Clinical Characteristics Related to Suicidal Behaviors Among Outpatients With Opioid Use Disorder: A Cross-Sectional Study.”. Journal of Opioid Management 21 (6): 483-94.

Yum, Seungil. 2026. “Spatial Responses and Displacements According to Hurricane Michael.”. Journal of Emergency Management (Weston, Mass.) 24 (1): 47-60.

Tiwari, Bishal, and Samita Sapkota. 2025. “Optimising Multiple Myeloma Therapy in Resource-Limited Settings: Current Perspectives and Challenges.”. Ecancermedicalscience 19: 2005.

Kurup, Anupama, and Deepak Charles. 2025. “A Rare Case of Diffuse Large B-Cell Lymphoma Masquerading As Guillain Barre Syndrome, Warburg Phenomenon and Hemophagocytic Lymphohistiocytosis.”. Ecancermedicalscience 19: 2012.

Barjij, Imad, and Meryem Meliani. 2025. “Cancer Stem Cells and Post-Therapy Tumour Recurrence: A Systematic Review of Mechanistic Pathways and Translational Gaps.”. Ecancermedicalscience 19: 2016.

Gabriel, Israel, Andy Emmanuel, P Pratitha, Divitha Subramanian, Thilaka Chandanee, and Fariba Hosseinisazi. 2025. “EHealth Tools to Improve the Health-Related Quality of Life of Family Caregivers of Cancer Patients in Developing Countries: A Systematic Review Protocol.”. Ecancermedicalscience 19: 2015.

Thota, Ravi Chandra, Sarawat Murtaza Sara, Md Yusuf Sarwar Uddin, Majid Bani-Yaghoub, and Gary Sutkin. 2024. “Accurate Estimation of Individual Transmission Rates Through Contact Analytics Using UWB Based Indoor Location Data.”. International Conference on Smart Applications, Communications and Networking : SmartNets. International Conference on Smart Applications, Communications and Networking 2024.

Wigger, Larry. Submitted. “Economic Power, Institutional Tensions, and Societal Futures: An Institutional Analysis of Robert Heinlein’s Speculative Fiction”. Journal of Economic Issues, Submitted.

Duman, Nesrin Caglayan. 2025. “Infection and Infestation-Related Adverse Events of Ocrelizumab: A Disproportionality Analysis Using FDA Adverse Event Reporting System.”. Northern Clinics of Istanbul 12 (5): 569-75.